Medroxyprogesterone opposes estradiol-induced renal damage in midlife ovariectomized Long Evans rats
Conclusion:
MPA was protective against E2-induced renal damage and dysfunction in middle-aged female Long Evans rats. Assessing the impact of hormone therapy on renal outcomes may be an important clinical factor when considering treatment options for postmenopausal women.
Source: Menopause - Category: OBGYN Tags: Original Studies Source Type: research
More News: Cardiology | Estradiol | Heart | Hormonal Therapy | Hormones | Hypertension | Laboratory Medicine | Medroxyprogesterone | Men | Menopause | OBGYN | Proteinuria | Study | Urology & Nephrology | Women